MERS-CoV

MERS-CoV

Biodefense Headlines – 13 July 2025

News Scan July 13, 2025

This week’s topics include cuts to CDC and USAID that threaten global biodefense, breakthrough vaccines for Nipah and CCHF, and confirmation of airborne H5N1 transmission in mammals. Also: Rwanda’s rapid…

Inovio’s Positive First-in-Human MERS Vaccine Results Published in The Lancet Infectious Diseases

Adaptive Evolution of MERS-CoV to Infect Different Species

MERS-CoV: Clinical Trial Starts for Regeneron’s Monoclonal Antibody Treatments

Experimental MERS Antibody Therapeutics Enter Clinical Trial

WHO Updates Blueprint List of Priority Diseases

New Coalition for Epidemic Preparedness Sets Sights on MERS-CoV, Lassa and Nipah

Turnkey Detection: Rapid Diagnostics in the Field

BARDA Backs Antibody Therapy Against MERS Virus

First-In-Human Study of MERS Vaccine Completes Enrollment

NIH Evaluating New Antibody Treatment for MERS-CoV

MERS-CoV Less Virulent During Outbreak?

MERS-CoV Likely Began in Bats, Moved to Camels, Then People

Walter Reed Kicks Off Phase 1 MERS Vaccine Trial

Inovio and GeneOne Kick Off MERS Vaccine Trial

Report Outlines Framework for Global Pandemic Preparedness

New Vaccine Against MERS Tested on Dromedary Camels

World Vaccine Congress 2016

PHEMCE Medical Countermeasure Stakeholders Workshop

Rapid Medical Countermeasure Response to Infectious Diseases

Kenya: MERS Virus Widespread in Camels

Biodefense Headlines – 13 July 2025